Construction of eukaryotic expression vector for human CCL21 and characterization of its chemotactic activity

Chinese Journal of Cancer Research

Volumn 18, Issue 4, 2006, Pages 246-250

  Hou, Li ^a,b   Liu, Qi ^a   Jiao, Yu Lian ^a   Jie, Zhang ^a   Wang, Lai Cheng ^a   Ma, Chun Yan ^a   Cui, Bin ^a   Zhang, Xue ^a   Zhao, Yue Ran ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Blood Center   (China)

Author keywords

CC chemokine ligand 21; Chemotaxis assay; Eukaryotic expression; Gene therapy

Indexed keywords

ENDONUCLEASE; ENDONUCLEASE XHO 1; SECONDARY LYMPHOID TISSUE CHEMOKINE; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GENE THERAPY; CHEMOTAXIS; CONTROLLED STUDY; ELECTROPHORESIS; EUKARYOTIC CELL; GENETIC TRANSFECTION; IN VITRO STUDY; LYMPHOCYTE; NONHUMAN; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; WESTERN BLOTTING;

EID: 33947160045     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11670-006-0246-z     Document Type: Article

References (15)

1. Cyster J. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs[J]. J Exp Med 1999; 189: 447-50.
2. Riedl K, Baratelli F, Batra RK, et al. Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells[J]. Mol Cancer 2003; 2: 35-48.
3. Sambrook J, Fritsch E F, Maniatis T. Molecular Cloning: A Laboratory Manual[M]. 2nd ed. New York: Cold Spring Harbor Laboratory Press 1989; 9:880.
4. Elizabeth A. Baker, Michael W, et al. Choices in Transfection Methodologies: Transfection Efficiency Should Not Be the Sole Criterion[J]. Focus 2000; 22: 30-2.
5. Mitchell A, Dass CR, Sun LQ, et al. Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumor growth by DNAzymes targeting the zinc finger transcription factor EGR-1[J]. Nucleic Acids Res 2004; 32:10 3065-9.
6. Guo JQ, Chen L, Ai HW, et al. A novel fusion protein of IP10-scFv retains antibody specificity and chemokine function[J]. Biochem Biophys Res Commun 2004; 320:506-13.
7. Gunn M D, Tangemann K, Tam C, et al. A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes[J]. Proc Natl Acad Sci USA. 1998; 95: 258-63.
8. Kirk CJ, Hartigan OD, Nickoloff BJ, et al. T Cell-dependent Antitumor Immunity Mediated by Secondary Lymphoid Tissue Chemokine Augmentation of Dendritic Cell-based Immunotherapy[J]. Cancer Res 2001; 61:2062-70.
9. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity[J]. Immunity 2000; 12: 121-7.
10. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues[J]. Nat Rev Immunol 2002; 2: 957-65.
11. Takeuchi H, Fujimoto A, Tanaka M, et al. CCL21 Chemokine Regulates Chemokine Receptor CCR7 Bearing Malignant Melanoma Cells[J]. Clin Cancer Res 2004; 10: 2351-8.
12. Yang SC, Hillinger S, Riedl K, et al. Intratumoral Administration of Dendritic Cells Overexpressing CCL21 Generates Systemic Antitumor Responses and Confers Tumor Immunity[J]. Clin Cancer Res 2004; 10:2891-901.
13. Sharma S, Stolina M, Zhu L. et al. Secondary Lymphoid Organ Chemokine Reduces Pulmonary Tumor Burden in Spontaneous Murine Bronchoalveolar Cell Carcinoma1[J]. Cancer res 2001; 61: 6406-12.
14. Sharma S, Stolina M, Luo J, et al. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo[J]. J Immunol 2000; 164: 4558-63.
15. Arenberg DA, Zlotnick A, Strom SRB, Burdick MD, Strieter RM. The murine CC chemokine, 6-Ckine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model[J]. Cancer Immunol Immunother 2000; 49: 587-92.